Steven Sparks

Company: Arvinas

Job title: Senior Research Fellow

Seminars:

Identification of Potent, Selective, Orally Bioavailable LRRK2 PROTAC® Protein Degraders for the Treatment of Neurodegenerative Diseases 9:00 am

Spotlighting orally bioavailable, brain penetrant PROTAC® therapies in development for the removal of disease-causing proteins as treatments for neurodegenerative diseases at Arvinas Demonstrating how activating mutations in leucine rich repeat kinase 2 (LRRK2) predispose patients to the development of Parkinson’s Disease (PD) and affect the course of disease progression in Progressive Supranuclear Palsy (PSP) Identifying…Read more

day: Day 1